{"quote": {"result": [{"language": "en-US", "region": "US", "quoteType": "EQUITY", "typeDisp": "Equity", "quoteSourceName": "Nasdaq Real Time Price", "triggerable": true, "customPriceAlertConfidence": "HIGH", "currency": "USD", "regularMarketChangePercent": 1.9801961, "regularMarketPrice": 1.03, "exchange": "NMS", "shortName": "Passage Bio, Inc.", "longName": "Passage Bio, Inc.", "messageBoardId": "finmb_602462727", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EDT", "gmtOffSetMilliseconds": -14400000, "market": "us_market", "esgPopulated": false, "marketState": "PRE", "firstTradeDateMilliseconds": 1582900200000, "tradeable": false, "cryptoTradeable": false, "priceHint": 4, "regularMarketChange": 0.01999998, "regularMarketTime": 1684180805, "regularMarketDayHigh": 1.06, "regularMarketDayRange": "1.0 - 1.06", "regularMarketDayLow": 1.0, "regularMarketVolume": 123430, "regularMarketPreviousClose": 1.01, "bid": 0.0, "ask": 0.0, "bidSize": 9, "askSize": 10, "fullExchangeName": "NasdaqGS", "financialCurrency": "USD", "regularMarketOpen": 1.02, "averageDailyVolume3Month": 162535, "averageDailyVolume10Day": 95990, "fiftyTwoWeekLowChange": 0.07999998, "fiftyTwoWeekLowChangePercent": 0.08421051, "fiftyTwoWeekRange": "0.95 - 2.885", "fiftyTwoWeekHighChange": -1.855, "fiftyTwoWeekHighChangePercent": -0.64298093, "fiftyTwoWeekLow": 0.95, "fiftyTwoWeekHigh": 2.885, "earningsTimestamp": 1683802850, "earningsTimestampStart": 1690979400, "earningsTimestampEnd": 1691411400, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "epsTrailingTwelveMonths": -2.5, "epsForward": -1.62, "epsCurrentYear": -2.07, "priceEpsCurrentYear": -0.49758455, "sharesOutstanding": 54626700, "bookValue": 3.687, "fiftyDayAverage": 1.05828, "fiftyDayAverageChange": -0.02828002, "fiftyDayAverageChangePercent": -0.026722625, "twoHundredDayAverage": 1.38662, "twoHundredDayAverageChange": -0.35662007, "twoHundredDayAverageChangePercent": -0.2571866, "marketCap": 56265500, "forwardPE": -0.63580245, "priceToBook": 0.2793599, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "averageAnalystRating": "1.6 - Buy", "displayName": "Passage Bio", "symbol": "PASG"}], "error": null}, "summary": {"result": [{"assetProfile": {"address1": "One Commerce Square", "address2": "39th Floor 2005 Market Street", "city": "Philadelphia", "state": "PA", "zip": "19103", "country": "United States", "phone": "267 866 0311", "website": "https://www.passagebio.com", "industry": "Biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "longBusinessSummary": "Passage Bio, Inc., a genetic medicines company, develops transformative therapies for central nervous system diseases. It develops PBGM01, a functional GLB1 gene encoding \u00df-galactosidase for infantile GM1; PBFT02, a functional granulin (GRN) and gene encoding progranulin (PGRN) for the treatment of FTD caused by progranulin deficiency; and PBKR03, a functional GALC gene encoding the hydrolytic enzyme galactosylceramidase for infantile Krabbe disease. The company also develops PBML04 for the treatment of metachromatic leukodystrophy; PBAL05 for the treatment of amyotrophic lateral sclerosis; and other program for huntington's disease. Passage Bio, Inc. has a strategic research collaboration with the Trustees of the University of Pennsylvania's Gene Therapy Program; and collaboration agreement, and a development services and clinical supply agreement with Catalent Maryland, Inc. The company was incorporated in 2017 and is headquartered in Philadelphia, Pennsylvania.", "fullTimeEmployees": 85, "companyOfficers": [{"maxAge": 1, "name": "Dr. William  Chou M.D.", "age": 49, "title": "Pres, CEO & Director", "yearBorn": 1973, "fiscalYear": 2022, "totalPay": {"raw": 395425, "fmt": "395.43k", "longFmt": "395,425"}, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Ms. Simona  King", "age": 50, "title": "CFO & Corp. Sec.", "yearBorn": 1972, "fiscalYear": 2022, "totalPay": {"raw": 632912, "fmt": "632.91k", "longFmt": "632,912"}, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Mr. Alexandros  Fotopoulos MBA, MSc", "age": 53, "title": "Chief Technical Officer", "yearBorn": 1969, "fiscalYear": 2022, "totalPay": {"raw": 653968, "fmt": "653.97k", "longFmt": "653,968"}, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Mr. Edgar B. Cale Esq., J.D.", "age": 58, "title": "Gen. Counsel & Company Sec.", "yearBorn": 1964, "fiscalYear": 2022, "totalPay": {"raw": 674358, "fmt": "674.36k", "longFmt": "674,358"}, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Dr. James M. Wilson M.D., Ph.D.", "age": 67, "title": "Co-Founder & Chief Scientific Advisor", "yearBorn": 1955, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Mr. Stuart M. Henderson", "title": "Sr. VP of Corp. Devel. & Investor Relations", "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Gregory  Fuest", "title": "VP of Global Commercial Strategy & Marketing", "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Dr. Mark  Forman M.D., Ph.D.", "age": 58, "title": "Chief Medical Officer", "yearBorn": 1964, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}], "auditRisk": 6, "boardRisk": 6, "compensationRisk": 9, "shareHolderRightsRisk": 8, "overallRisk": 7, "governanceEpochDate": 1682899200, "compensationAsOfEpochDate": 1672444800, "maxAge": 86400}}], "error": null}}